Raymond James Financial Services Advisors, Inc. Moderna, Inc. Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 84,193 shares of MRNA stock, worth $2.99 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

84,193

Previous 76,931 9.44%

Holding current value

$2.99 Million

Previous $9.14 Million 38.41%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$63.64 - $125.14 $462,153 - $908,766	7,262 Added 9.44%	84,193 $5.63 Million
Q2 2024 Jul 19, 2024	BUY	$101.21 - $166.61 $1.04 Million - $1.71 Million	10,259 Added 15.39%	76,931 $9.14 Million
Q1 2024 Apr 22, 2024	BUY	$85.37 - $115.44 $711,473 - $962,076	8,334 Added 14.29%	66,672 $7.1 Million
Q4 2023 Jan 16, 2024	BUY	$69.51 - $104.43 $108,018 - $162,284	1,554 Added 2.74%	58,338 $5.8 Million
Q3 2023 Oct 24, 2023	SELL	$96.41 - $126.61 $546,837 - $718,131	-5,672 Reduced 9.08%	56,784 $5.87 Million
Q2 2023 Jul 25, 2023	BUY	$118.5 - $160.53 $1.07 Million - $1.44 Million	9,001 Added 16.84%	62,456 $7.59 Million
Q1 2023 Apr 14, 2023	BUY	$135.66 - $197.02 $1.27 Million - $1.85 Million	9,386 Added 21.3%	53,455 $8.21 Million
Q4 2022 Feb 08, 2023	SELL	$118.38 - $210.04 $13,140 - $23,314	-111 Reduced 0.25%	44,069 $7.92 Million
Q3 2022 Oct 25, 2022	SELL	$118.07 - $194.18 $183,008 - $300,979	-1,550 Reduced 3.39%	44,180 $5.22 Million
Q2 2022 Aug 12, 2022	SELL	$117.13 - $176.59 $4.36 Million - $6.57 Million	-37,228 Reduced 44.88%	45,730 $6.53 Million
Q1 2022 May 11, 2022	BUY	$126.46 - $235.05 $275,809 - $512,644	2,181 Added 2.7%	82,958 $14.3 Million
Q4 2021 Feb 08, 2022	SELL	$225.82 - $368.51 $6.7 Million - $10.9 Million	-29,660 Reduced 26.86%	80,777 $20.5 Million
Q3 2021 Nov 02, 2021	SELL	$221.9 - $484.47 $2.24 Million - $4.9 Million	-10,105 Reduced 8.38%	110,437 $42.5 Million
Q2 2021 Aug 11, 2021	BUY	$129.91 - $234.98 $5.66 Million - $10.2 Million	43,594 Added 56.65%	120,542 $28.3 Million
Q1 2021 May 14, 2021	BUY	$109.18 - $185.98 $1.53 Million - $2.61 Million	14,044 Added 22.33%	76,948 $10.1 Million
Q4 2020 Feb 12, 2021	SELL	$65.74 - $169.86 $1.72 Million - $4.45 Million	-26,192 Reduced 29.4%	62,904 $6.57 Million
Q3 2020 Nov 04, 2020	SELL	$54.34 - $94.85 $35,321 - $61,652	-650 Reduced 0.72%	89,096 $6.3 Million
Q2 2020 Jul 17, 2020	BUY	$29.67 - $80.0 $867,165 - $2.34 Million	29,227 Added 48.29%	89,746 $5.76 Million
Q1 2020 Apr 21, 2020	BUY	$17.78 - $31.58 $472,396 - $839,049	26,569 Added 78.26%	60,519 $1.81 Million
Q4 2019 Feb 12, 2020	BUY	$13.93 - $21.28 $50,287 - $76,820	3,610 Added 11.9%	33,950 $664,000
Q3 2019 Nov 07, 2019	BUY	$12.26 - $18.07 $193,744 - $285,560	15,803 Added 108.71%	30,340 $483,000
Q2 2019 Aug 06, 2019	BUY	$13.7 - $28.34 $199,156 - $411,978	14,537 New	14,537 $213,000

Others Institutions Holding MRNA

# of Institutions

922

Shares Held

255M

Call Options Held

19M

Put Options Held

24.3M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $13.9B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account

Raymond James Financial Services Advisors, Inc. Moderna, Inc. Transaction History